Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 34 of 100
Finance
Will we have a COVID-19 vaccine this year? Here’s what the prediction markets say
By
Tech Reporter
July 15, 2020
Newsletters
One nonprofit’s ambitious new innovation for rare blood cancer patients
By
Contributing Writer
July 14, 2020
Health
A nonprofit just announced a 23andMe-like genomic sequencing model for a rare cancer—but it’s free
By
Contributing Writer
July 14, 2020
Health
Gilead says remdesivir slashes coronavirus deaths. But it’s complicated
By
News Correspondent
July 10, 2020
Health
You can now sign up to participate in COVID-19 vaccine clinical trials
By
Crypto Correspondent
July 9, 2020
Commentary
In the COVID-19 vaccine race, nobody wins unless everyone wins
By
Senior Editor
July 8, 2020
Finance
A dose of good news: Pfizer shares surge on coronavirus vaccine trial
By
Blockchain Reporter
July 1, 2020
Health
COVID treatment remdesivir will cost $520 per vial. But it may not be how much you pay
By
Financial Writer
June 29, 2020
Health
Gilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By
Robert Langreth
and
Bloomberg
June 29, 2020
Health
Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals
By
Industry Analyst
June 22, 2020
Health
Court rules Trump can’t require drugmakers to disclose prices in TV ads
By
Industry Analyst
June 18, 2020
Health
How the first-ever digital ADHD treatment—a video game—got the FDA’s blessing
By
Investment Desk
June 17, 2020
Newsletters
A second coronavirus wave isn’t imminent—the first one never ended
By
Research Team
June 11, 2020
Health
Rumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By
Digital Assets Editor
June 8, 2020
Health
5 companies to keep an eye on following the world’s largest cancer conference
By
Market Analyst
June 3, 2020
Most Popular
Politics
Trump's FAA punishes most of nation's air traffic workers by only giving $10,000 bonuses to the 776 with perfect...
By
Josh Funk
and
The Associated Press
Banking
Suddenly, the Fed interest rate cut in December looks like it is very much back on the table
By
Crypto Correspondent
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Contributing Writer